Geneos Wealth Management Inc. Bristol Myers Squibb CO Transaction History
Geneos Wealth Management Inc.
- $2.77 Billion
- Q4 2024
A detailed history of Geneos Wealth Management Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 95,955 shares of BMY stock, worth $5.48 Million. This represents 0.2% of its overall portfolio holdings.
Number of Shares
95,955
Previous 92,395
3.85%
Holding current value
$5.48 Million
Previous $4.78 Million
13.51%
% of portfolio
0.2%
Previous 0.18%
Shares
36 transactions
Others Institutions Holding BMY
# of Institutions
2,555Shares Held
1.46BCall Options Held
31.6MPut Options Held
35M-
Vanguard Group Inc Valley Forge, PA189MShares$10.8 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.06 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.3 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.45 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.48 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $121B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...